文献速递外周动脉疾病

单中心下肢血运重建后外周动脉疾病的自然病史

The Natural History of Peripheral Arterial Disease Following Lower Extremity Revascularization at a Single Institution.
PubMed 文献 · Ann Vasc Surg · 2025-03-06

该前瞻性单中心研究纳入2020年12月至2023年12月因外周动脉疾病行下肢血运重建的277例患者(女性35%,平均年龄69岁),随访至2024年3月或失访,记录主要事件。结果显示21.3%需再次血运重建,16%发生初期血管并发症,11%截肢,死亡率为10%。

要点

  • 21.3%的患者需至少一次同侧下肢再次外科血运重建。
  • 16%发生初期血管并发症,其中闭塞11%、狭窄5%。
  • 截肢率11%,主要因伤口恶化(48%)和感染(23%)。

核心结论

  • 21.3%的患者需至少一次同侧下肢再次外科血运重建,研究随访期间总死亡率为10%。
  • 了解发病率、死亡率和疾病进展风险有助于血管外科医生为接受下肢血运重建的外周动脉疾病患者提供咨询。

研究设计与样本

  • 前瞻性单中心研究,纳入2020年12月至2023年12月在本机构因外周动脉疾病行下肢血运重建的患者。
  • 随访自索引手术至2024年3月或失访,记录并分析索引血运重建后的主要事件。
  • 共纳入277例患者,女性占35%,平均年龄69岁。

主要发现

  • 21.3%的患者需要术后血运重建。
  • 16%的患者发生初期血管并发症,其中11%为闭塞、5%为狭窄;部位特异性并发症影响10%的病例。
  • 11%的患者需截肢,主要驱动因素为伤口恶化(48%)和感染(23%)。
  • 继发性并发症包括出血事件(9%)、感染/伤口裂开(5%)和血栓事件(1%)。
  • 死亡率为10%,患者术后平均生存4.4个月。

临床怎么用

  • 了解发病率、死亡率和疾病进展风险可帮助血管外科医生为接受下肢血运重建的外周动脉疾病患者提供咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral artery disease (PAD) is widely prevalent, affecting more than 200 million people worldwide. However, the natural history of this disease process following lower extremity revascularization has not been fully delineated. We aimed to analyze this disease process with particular attention to subsequent interventions, wound complications, and mortality. METHODS: We conducted a prospective single-institution study that included patients who underwent lower extremity revascularization for PAD at our institute from December 2020 to December 2023. Patients were followed from the time of their index surgery through March 2024 or until they were lost to follow-up. Major events after the index revascularization were documented and analyzed. RESULTS: The study included 277 patients (35% female) with a mean age of 69 years. In this cohort, 21.3% of patients required postsurgical revascularization. Initial vascular complications occurred in 16% of patients, with 11% experiencing occlusion and 5% developing stenosis, while site-specific complications affected 10% of cases. Amputation was necessary in 11% of patients, primarily driven by worsening wounds (48%) and infection (23%). Secondary complications included bleeding events (9%), infection/wound dehiscence (5%), and thrombotic events (1%). The study revealed a 10% mortality rate, with patients surviving an average of 4.4 months post surgery. CONCLUSION: We found that 21.3% of patients required at least one additional surgical revascularization of the ipsilateral leg, and the overall mortality rate during the study follow-up period was 10%. Knowledge of the risks of morbidity, mortality, and progression of disease can help vascular surgeons counsel patients undergoing lower extremity revascularization for PAD.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cieri IF, Rodriguez Alvarez AA, Boya MN, et al. The Natural History of Peripheral Arterial Disease Following Lower Extremity Revascularization at a Single Institution. Ann Vasc Surg. 2025. PMID: 40057269. doi:10.1016/j.avsg.2025.01.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。